The free, virtual platform provides access to expert physicians in the field of osteosarcoma who serve as reliable resources and support during a patient’s greatest time of need.
OSI’s Strategic Advisory Board and Scientific Committees Break Down Barriers in the Name of Advancing Research
World-renowned experts and researchers come together to accelerate and improve progress in finding a cure for osteosarcoma.
Vanessa joins the Osteosarcoma Institute with a background in corporate communications, fundraising and grant writing for medical research.
OSI Director Lee Helman, MD, looks at where we started, where we are, and where we’re going.
OSI is thrilled to welcome Amy Lobner, MPH, CCRC, who brings with her a vast skill set rooted in clinical research and scientific development.
With more than 20 years of expertise studying rare diseases, Dr. Arnaldez is working to remove barriers to developing osteosarcoma treatments.
A leading computational biologist and researcher at St. Jude Children’s Research Hospital, Dr. Zhang is passionate about advancing osteosarcoma treatment.
Pediatric oncologist and researcher, Richard Gorlick, MD, is on a mission to improve osteosarcoma outcomes.
After receiving a record 26 proposals, Lee Helman, MD, shares the three winning projects the institute is funding in its quest improve treatment and, ultimately, eradicate osteosarcoma.